Tesamorelin (10 mg) · Ipamorelin (3 mg) (Blend)

Tesamorelin · Ipamorelin is a research blend that combines two peptides: Tesamorelin and Ipamorelin. In a research context, this pairing is studied for growth hormone signaling, endocrine regulation, and metabolic communication in controlled models.

Each peptide is also studied on its own, and putting them in one vial lets researchers look at how a GHRH analog and a secretagogue work side by side across overlapping signaling pathways (Falutz et al., 2010, Journal of Clinical Endocrinology). That shared pathway is a common reason peptides are studied as a blend.

Research Applications

• Growth hormone signaling research
• Endocrine regulation studies
• Metabolic pathway research
• Multi-peptide combination research

Supplied as a lyophilized powder for stability.

See also: Tesamorelin, Ipamorelin 10 mg, and CJC-1295 (No DAC) + Ipamorelin (10 mg) (Blend).

Net peptide content per vial: 10 mg + 3 mg